(Related to Fig 2): The circadian DN1p and sCPDN3 signal to LPN. حسب Xin Yuan (174619)

Primers for quantitative real-time PCR. حسب Ya-nan Hu (12508990)

"…However, LDLR protein levels in the cell lysate of both the Gly343Ser and Ala627Thr variants groups were significantly lower than those in the wild-type group. …"

Descriptive data for the pBT-child dyads. حسب Madalina Ciobanu (2504683)

"…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …"

CFQL-2 descriptive statistics. حسب Madalina Ciobanu (2504683)

"…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …"

O₂ concentration under different conditions. حسب Zihao Chai (20521844)

"…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …"

This is the paper’s data. حسب Zihao Chai (20521844)

"…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …"

O₂ concentration under different conditions. حسب Zihao Chai (20521844)

"…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …"

Velocity of postural sway in the four sensory conditions before and after napping. حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the beta band (13-21 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the fast beta band (22-30 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the alpha band (8-12 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the theta band (4-7 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the gamma band (31-50 Hz). حسب Hui-Ya Chen (13919141)

Frequency of postural sway in the four sensory conditions before and after napping. حسب Hui-Ya Chen (13919141)

Participant flow (CONSORT diagram). حسب David J. Diemert (8135568)

"…Peak anti-<i>Na</i>-GST-1 IgG levels were observed between 2 and 4 weeks following the third dose, regardless of <i>Na</i>-GST-1 formulation. IgG levels decreased but remained significantly above baseline in all groups by day 290, at which point all participants (20 of 20 evaluable participants) still had detectable IgG. …"

A mathematical model of PIF4 autoregulation captures the experimental observations of hypocotyl growth and promoter activity. حسب Sreya Das (20531295)

Study data. حسب Jie Liu (15128)

"…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…"

Summary of clinical outcomes after 9 months. حسب Jie Liu (15128)

"…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…"

Approval by the research ethics committee. حسب Jie Liu (15128)

"…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…"

Basic information and patient characteristics according to the report. حسب Xiaoling Zhong (181270)